NDC 80425-0189-01 - Diclofenac Sodium DR
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0189
- Requested NDC
- 80425-0189-01
- Package NDCs from labels
- 80425-0189-1, 80425-0189-2, 80425-0189-3, 80425-0189-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Diclofenac Sodium DR - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0189-1 | Diclofenac SodiumDR | 60 in 1 BOTTLE | TABLET, DELAYED RELEASE | 60 | 6 | |
| 80425-0189-2 | Diclofenac SodiumDR | 30 in 1 BOTTLE | TABLET, DELAYED RELEASE | 30 | 6 | |
| 80425-0189-3 | Diclofenac SodiumDR | 90 in 1 BOTTLE | TABLET, DELAYED RELEASE | 90 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0189 | DICLOFENAC SODIUM DR (DICLOFENAC SODIUM) TABLET, DELAYED RELEASE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 6 | Current NDC, Legacy NDC, 3 package rows | 20250101_d424ab84-2aaa-38a9-e053-2a95a90adde9.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0189-1 | EA - Each | 80425-0189 | 1cc1ed3c-bfe6-449b-8220-36962f0168af | 1 | 2023-03-13 |
| 80425-0189-2 | EA - Each | 80425-0189 | b2b4c1f7-3353-4bcb-947e-56e9782f23ed | 1 | 2023-04-07 |
| 80425-0189-3 | EA - Each | 80425-0189 | 0d40ec80-d802-40a2-b8c1-d0f7c388ca59 | 1 | 2023-04-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Diclofenac Sodium | DICLOFENAC | PHOENIX RX LLC | 41dab520-5651-a4c5-e063-6394a90a2962 | 2025-10-23 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | BluePoint Laboratories | feb1541a-de83-47dd-be03-c43376527318 | 2025-10-14 | Boxed warning, Warnings, Adverse reactions | 855926 855906 QTG126297Q |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM TOPICAL GEL, 1% | Encube Ethicals, Inc. | 6e8c45e1-8cd4-4ff7-a758-f9d2ed37e593 | 2025-10-01 | Warnings | QTG126297Q |
| ARTHRITIS PAIN RELIEVING | DICLOFENAC SODIUM | Walgreen Company | b1850a16-54f1-4210-abdf-26414da8b3d9 | 2025-09-29 | Warnings | QTG126297Q |
| FOSTER AND THRIVE ARTHRITIS PAIN | DICLOFENAC SODIUM | Strategic Sourcing Services LLC | f9f4e55f-ffad-4df7-9b3c-1e7c3a3723c1 | 2025-09-27 | Warnings | QTG126297Q |
| DG HEALTH ARTHRITIS PAIN | DICLOFENAC SODIUM | Dolgencorp Inc | 6479e4bb-0790-483e-bfe3-a54d549aa5d2 | 2025-09-15 | Warnings | QTG126297Q |
| Diclofenac Sodium and Misoprostol | DICLOFENAC SODIUM AND MISOPROSTOL | BluePoint Laboratories | 9a22cb4b-e49a-4bd7-b235-47405c302658 | 2025-09-11 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | PHOENIX RX LLC | 3e15c3db-5245-76fb-e063-6394a90a814e | 2025-09-08 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclona | LIDOCAINE 4.5%, DICLOFENAC 1% | Preferred Pharmaceuticals Inc. | 4cc1d80b-2435-404f-949f-bd207a863631 | 2025-09-05 | Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | A-S Medication Solutions | 4c5b722e-0d1a-48e9-87c8-9b370b8ced46 | 2025-09-05 | Boxed warning, Warnings, Adverse reactions | 855926 QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Bryant Ranch Prepack | 4e97c685-628a-4b83-ba9e-2d3caf65542b | 2025-09-04 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Advanced Rx of Tennessee, LLC | 3d71f76d-bb23-7251-e063-6394a90aa9d8 | 2025-08-27 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac sodium | DICLOFENAC SODIUM | Best Choice (Valu Merchandisers Company) | 4ea809a9-387a-4193-a176-d8b22eaa55e6 | 2025-08-21 | Warnings | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | A-S Medication Solutions | ca0f9295-4933-48d6-9387-90345fd5dcaa | 2025-08-20 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| ARTHROTEC | DICLOFENAC SODIUM AND MISOPROSTOL | Pfizer Laboratories Div Pfizer Inc | 600fe842-45d9-4d68-9ef2-456dbbebaa11 | 2025-08-14 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM TOPICAL GEL, 1% | BluePoint Laboratories | 274543d2-a9a6-1e37-e063-6394a90ae3f1 | 2025-08-11 | Warnings | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | Rising Pharma Holdings, Inc. | 3330ea92-fc9d-4541-b378-be399b0995d3 | 2025-08-05 | Boxed warning, Warnings, Adverse reactions | 855926 855906 QTG126297Q |
| Diclofenac Sodium/Misoprostol DICLOFENAC-SODIUM-MISOPROSTOL | DICLOFENAC SODIUM/MISOPROSTOL | Micro Labs Limited | c61df58d-d6bb-4d3e-9ef8-60caa7d4e762 | 2025-07-28 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM | PHOENIX RX LLC | 3a4f7301-aa1c-9064-e063-6294a90a6eb4 | 2025-07-21 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
| Diclofenac Sodium | DICLOFENAC SODIUM TOPICAL | PHOENIX RX LLC | 3a63e26f-27d7-9a25-e063-6294a90a55fe | 2025-07-20 | Boxed warning, Warnings, Adverse reactions | QTG126297Q |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.